Oncogenex logo
Exited company

Oncogenex

Details
Region
Prairies and West
Industry sector
Medical/health
Investment year
2002
Fund
Healthcare Venture Fund
About the company

OncoGenex is a biopharmaceutical company uniquely focused on cancer treatment resistance. It is committed to the development and commercialization of first-in-class, innovative therapies that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.